يعرض 1 - 14 نتائج من 14 نتيجة بحث عن '"остеобласт"', وقت الاستعلام: 0.46s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المؤلفون: Savchenko, O. V.

    المصدر: Bulletin of Scientific Research; No. 4 (2017) ; Вестник научных исследований; № 4 (2017) ; Вісник наукових досліджень; № 4 (2017) ; 2415-8798 ; 1681-276X ; 10.11603/2415-8798.2017.4

    وصف الملف: application/pdf

  3. 3
    Academic Journal

    وصف الملف: application/pdf

    Relation: Ponyrko A, Bumeister V, Korenkov O, Dmytruk S, Kiptenko L, Ryabenko T, Teslyk T, Ryabenko D. [Structural and functional changes in osteogenic cells and biomarkers of bone remodeling in chronic hyperglycemia]. East Ukr Med J. 2023;11(4):398-407. DOI: https://doi.org/10.21272/eumj.2023;11(4):398-407; https://essuir.sumdu.edu.ua/handle/123456789/94188

  4. 4
    Academic Journal

    Relation: Качиева, З.С., Габдулина, Г.Х., Накисбеков, Н.О. 2016. Определение полиморфизмов гена dkk1 у больных с диагнозом остеоартрит. Книга абстрактов. 4 Международная научная конференция. “Regenerative medicine & healthy aging”. National Laboratory Astana, Назарбаев Университет. http://nur.nu.edu.kz/handle/123456789/1590.; http://nur.nu.edu.kz/handle/123456789/1590

  5. 5
    Academic Journal

    المساهمون: Франческа Агостини

    المصدر: Cancer Urology; Том 11, № 4 (2015); 81-88 ; Онкоурология; Том 11, № 4 (2015); 81-88 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2015-11-4

    وصف الملف: application/pdf

    Relation: https://oncourology.abvpress.ru/oncur/article/view/529/475; Santini D., Galluzzo S., Zoccoli A. et al. New molecular targets in bone metastases. Cancer Treat Rev 2010;36(Suppl 3):6–10.; O’Donnell A., Judson I., Dowsett M. et al. Hormonal impact of the 17alphahydroxylase/C(17,20)-lyase inhibitor Abiraterone acetate (CB7630) in patients with prostate cancer. Br J Cancer 2004;90:2317– 25.; Barrie S.E., Potter G.A., Goddard P.M. et al. Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase). J Steroid Biochem Mol Biol 1994;50:267–73.; De Bono J.S., Logothetis C.J., Molina A. et al. AA and increased survival in metastatic prostate cancer. N Engl J Med 2011;364:1995–2005.; Fizazi K., Scher H.I., Molina A. et al.Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase III study. Lancet Oncol 2012;13:983–92.; Ryan C.J., Smith M.R., de Bono J.S. et al. AAraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 2013;10;368:138–48.; Kawano H., Sato T., Yamada T. et al. Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 2003;100:9416–21.; Wiren K.M., Semirale A.A., Zhang X.W. et al. Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton. Bone 2008;43:440–51.; Chiang C., Chiu M., Moore A.J. et al. Mineralization and bone resorption are regulated by the androgen receptor in male mice. J Bone Miner Res 2009;24:621–31.; Falahati-Nini A., Riggs B.L., Atkinson E.J. et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000;106:1553–60.; Kousteni S., Chen J.R., Bellido T. et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002;298:843–6.; Kousteni S., Bellido T., Plotkin L.I. et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001;104:719–30.; Duc I., Bonnet P., Duranti V. et al. In vitro and in vivo models for the evaluation of potent inhibitors of male rat 17alphahydroxylase/C17,20-lyase. J Steroid BiochemMol Biol 2003;84:537–42.; Richards J., Lim A.C., Hay C.W. et al. Interactions of AAraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing; AAraterone exposure or combining with MDV3100. Cancer Res 2012;72:2176–82.; van Soest R.J., van Royen M.E., de Morrée E.S. et al. Cross-resistance between taxanes and new hormonal agents AAraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer. Eur J Cancer 2013;49: 3821–30.; Bruno R.D., Gover T.D., Burger A.M. et al. 17alpha-hydroxylase/17, 20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response. Mol Cancer Ther 2008;7:2828–36.; Hamamura K., Tanjung N., Yokota H. Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha. J Bone Miner Metab 2013;31:618–28.; Susa M., Luong-Nguyen N.H., Cappellen D. et al. Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay. J Transl Med 2004;2:6.; He W., Mazumder A., Wilder T., Cronstein B.N. Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma. FASEB J 2013;27:3446–54.; Yen M.L., Hsu P.N., Liao H.J. et al. TRAF-6 dependent signaling pathway is essential for TNF-related apoptosisinducing ligand (TRAIL) induces osteoclast differentiation. PLoS One 2012;7:e38048.; Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25: 402–8.; https://oncourology.abvpress.ru/oncur/article/view/529

  6. 6
  7. 7
  8. 8
    Academic Journal
  9. 9

    المصدر: Onkourologiâ, Vol 11, Iss 4, Pp 81-88 (2015)
    Oncotarget, 6 (14
    Oncotarget

    وصف الملف: 1 full-text file(s): application/pdf

  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
    Electronic Resource

    Additional Titles: АНАЛИЗ ИСПОЛЬЗОВАНИЯ ЛАЗЕРНОГО ИЗЛУЧЕНИЯ В ПРОЦЕССЕ ОРТОДОНТИЧНОГО ПЕРЕМЕЩЕНИЯ ЗУБОВ И ПРЕДЛОЖЕНИЯ ПО УСОВЕРШЕНСТВОВАНИЮ ТЕХНОЛОГИЙ
    АНАЛІЗ ВИКОРИСТАННЯ ЛАЗЕРНОГО ВИПРОМІНЮВАННЯ В ПРОЦЕСІ ОРТОДОНТИЧНОГО ПЕРЕМІЩЕННЯ ЗУБІВ ТА ПРОПОЗИЦІЇ ЩОДО ВДОСКОНАЛЕННЯ ТЕХНОЛОГІЇ

    المؤلفون: Savchenko, O. V.

    المصدر: Bulletin of Scientific Research; No. 4 (2017); Вестник научных исследований; № 4 (2017); Вісник наукових досліджень; № 4 (2017); 2415-8798; 1681-276X; 10.11603/2415-8798.2017.4